FindTrial
Sign In

Evaluation value and prognosis of multimodal CMR, computational and serological examinations in patients with non-ischemic cardiomyopathy

Multimodal CMR and left ventricular entropy combined biomarkers to optimize the risk of sudden death in patients with hypertrophic cardiomyopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049160
Enrollment
Unknown
Registered
2021-07-24
Start date
2022-03-01
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonischemic cardiomyopathy

Interventions

Case group:No

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with HCM after CMR examination; 2. History of cardiac surgery (septal ablation, valve replacement, etc.); 3. Equipped with ICD; 4. Confirmed comorbidity of diabetes; 5. Chronic lung disease, chronic renal failure; 6. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: Case group: Ischemic heart disease (via coronary angiography) with a history of cardiac surgery (ventricular septal ablation valve replacement, etc.) with ICD-proven comorbidities, diabetes, chronic lung disease, and chronic renal failure; Control group: Patients with a diagnosis of HCM and no ischemic heart disease (via coronary angiography), hypertensive heart disease, dilated cardiomyopathy, acute myocarditis, and arrhythmic right ventricular cardiomyopathy were excluded.

Design outcomes

Primary

MeasureTime frame
Multimodal Cardiac Magnetic Resonance Imaging;—

Countries

China

Contacts

Public ContactZhao Xiaoying

The Second Affiliated Hospital of Kunming Medical University

Amaranth1128@163.com+86 15911558758

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026